PSA-based machine learning model improves prostate cancer risk stratification in a screening population

被引：0
|
作者：
Marlon Perera
Rohan Mirchandani
Nathan Papa
Geoff Breemer
Anna Effeindzourou
Lewis Smith
Peter Swindle
Elliot Smith
机构：
[1] Mater Hospital,Department of Urology
[2] Austin Health,Department of Surgery
[3] The University of Melbourne,Faculty of Medicine
[4] University of Queensland,School of Public Health and Preventive Medicine
[5] Monash University,undefined
[6] Maxwell Plus,undefined
来源：
World Journal of Urology | 2021年 / 39卷
关键词：
Prostate cancer; Prostate-specific membrane antigen; Prostate cancer screening; Machine learning; Artificial intelligence;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1897 / 1902
页数：5
相关论文
共 50 条
  • [1] PSA-based machine learning model improves prostate cancer risk stratification in a screening population
    Perera, Marlon
    Mirchandani, Rohan
    Papa, Nathan
    Breemer, Geoff
    Effeindzourou, Anna
    Smith, Lewis
    Swindle, Peter
    Smith, Elliot
    WORLD JOURNAL OF UROLOGY, 2021, 39 (06) : 1897 - 1902
  • [2] Finding the PSA-based screening stopping age using prostate cancer risk
    Nahvijou, Azin
    Hadian, Mohammad
    Mohamadkhani, Naser
    CANCER TREATMENT AND RESEARCH COMMUNICATIONS, 2024, 38
  • [3] Unintended consequences of decreased PSA-based prostate cancer screening
    Ahlering, Thomas
    Huynh, Linda My
    Kaler, Kamaljot S.
    Williams, Stephen
    Osann, Kathryn
    Joseph, Jean
    Lee, David
    Davis, John W.
    Abaza, Ronney
    Kaouk, Jihad
    Patel, Vipul
    Kim, Isaac Yi
    Porter, James
    Hu, Jim C.
    WORLD JOURNAL OF UROLOGY, 2019, 37 (03) : 489 - 496
  • [4] Unintended consequences of decreased PSA-based prostate cancer screening
    Thomas Ahlering
    Linda My Huynh
    Kamaljot S. Kaler
    Stephen Williams
    Kathryn Osann
    Jean Joseph
    David Lee
    John W. Davis
    Ronney Abaza
    Jihad Kaouk
    Vipul Patel
    Isaac Yi Kim
    James Porter
    Jim C. Hu
    World Journal of Urology, 2019, 37 : 489 - 496
  • [5] Introduction to a seminar on revisiting the value of PSA-based prostate cancer screening
    Carlsson, Sigrid, V
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2023, 41 (02) : 76 - 77
  • [6] PSA-based screening for prostate cancer: How does it compare with other cancer screening tests?
    Crawford, E. David
    Abrahamsson, Per-Anders
    EUROPEAN UROLOGY, 2008, 54 (02) : 262 - 273
  • [7] PSA-based early detection of prostate cancer
    Luboldt, HJ
    Rübben, H
    UROLOGE A, 2000, 39 (01): : 22 - 26
  • [8] Implementation of PSA-based active surveillance in prostate cancer
    Jalloh, Mohamed
    Cooperberg, Matthew R.
    BIOMARKERS IN MEDICINE, 2014, 8 (05) : 747 - 753
  • [9] Current results on PSA-based prostate cancer detection
    Graefen, M.
    Schlomm, T.
    Steuber, T.
    Sauter, G.
    BUNDESGESUNDHEITSBLATT-GESUNDHEITSFORSCHUNG-GESUNDHEITSSCHUTZ, 2014, 57 (03) : 312 - 317
  • [10] PSA-based, prostate cancer risk on-line calculators: no such thing as a crystal ball?
    Lippi, Giuseppe
    Mattiuzzi, Camilla
    Plebani, Mario
    DIAGNOSIS, 2018, 5 (04) : 253 - 255
12345